Loading...
Entrectinib in patients with ROS1-positive NSCLC or NTRK fusion-positive solid tumors with CNS metastases
Paz-Ares, L Dziadziuszko, R Drilon, A John, T Krebs, Matthew G Demetri, G Shaw, A Siena, S Wolf, J Farago, A
Paz-Ares, L
Dziadziuszko, R
Drilon, A
John, T
Krebs, Matthew G
Demetri, G
Shaw, A
Siena, S
Wolf, J
Farago, A
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Paz-Ares L, Dziadziuszko R, Drilon A, John T, Krebs M, Demetri G, et al. MA14.02 Entrectinib in Patients with ROS1-Positive NSCLC or NTRK Fusion-Positive Solid Tumors with CNS Metastases. Journal of Thoracic Oncology. 2019;14(10):S305.